Argan (AGX) director sells 300 shares of stock at $705 each
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ARGAN INC director Karen Sweeney reported an open-market sale of company stock. On June 17, 2026, she sold 300 shares of Argan common stock at a price of $705 per share. After this transaction, she directly holds 1,548 shares of Argan common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 300 shares ($211,500)
Net Sell
1 txn
Insider
Sweeney Karen
Role
null
Sold
300 shs ($212K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 300 | $705.00 | $212K |
Holdings After Transaction:
Common Stock — 1,548 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 300 shares
Sale price: $705 per share
Shares held after sale: 1,548 shares
+1 more
4 metrics
Shares sold
300 shares
Open-market sale of Argan common stock on June 17, 2026
Sale price
$705 per share
Price for 300 Argan common shares sold on June 17, 2026
Shares held after sale
1,548 shares
Direct holdings of Argan common stock following the transaction
Net shares sold
300 shares
Net change in Argan share position from this reported transaction
Key Terms
open-market sale, Common Stock, Form 4
3 terms
open-market sale financial
"sold 300 shares of the Issuer's common stock on the open market at a price of $705 per share"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"the Issuer's common stock on the open market at a price of $705 per share"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"according to the Form 4 insider filing for June 17, 2026"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did ARGAN INC (AGX) director Karen Sweeney report?
Director Karen Sweeney reported an open-market sale of ARGAN INC common stock. She sold 300 shares in a single transaction and now directly holds 1,548 shares, according to the Form 4 insider filing for June 17, 2026.
What are Karen Sweeney’s ARGAN INC (AGX) holdings after this Form 4 sale?
After selling 300 shares, Karen Sweeney directly holds 1,548 ARGAN INC common shares. This post-transaction balance is disclosed in the Form 4 and represents her remaining direct ownership following the June 17, 2026 open-market sale.
Was the ARGAN INC (AGX) transaction by Karen Sweeney an open-market sale?
Yes. The Form 4 describes the transaction as an open-market sale of ARGAN INC common stock. She sold 300 shares at $705 per share, and this sale reduced her directly held position to 1,548 shares after the transaction.
When did ARGAN INC (AGX) director Karen Sweeney execute her reported stock sale?
Karen Sweeney executed the reported sale on June 17, 2026. On that date, she sold 300 shares of ARGAN INC common stock in an open-market transaction at a price of $705 per share, as detailed in the Form 4 filing.